Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Proescholdt

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Cancers|April 30, 2021
Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous MetaboliteRaffaela S Berger, Christian J Wachsmuth, Magdalena C Waldhier, et al.
Cancers|November 20, 2020
Non-Invasive Prediction of <i>IDH</i> Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo <sup>1</sup>H-Magnetic Resonance Spectroscopy and Machine LearningElisabeth Bumes, Fro-Philip Wirtz, Claudia Fellner, et al.
Cell Cycle (Georgetown, Tex.)|May 11, 2016
Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2Corinna Seliger, Anne-Louise Meyer, Kathrin Renner, et al.
Neuro-Oncology|December 22, 2021
Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastasesAnna-Katharina Meißner, Robin Gutsche, Norbert Galldiks, et al.
BMC Cancer|September 4, 2009
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II studyChristoph P Beier, Christina Schmid, Thierry Gorlia, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their CaregiversAnna Fischl, Michael Gerken, Patricia Lindberg-Scharf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2016
Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor MimicMarkus Hutterer, Yvonne Ebner, Markus J Riemenschneider, et al.
Molecular Oncology|January 18, 2025
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survivalBarnabas Irmer, Darius Wlochowitz, Carolin Krekeler, et al.
Journal of Neuro-Oncology|July 10, 2026
Leptomeningeal disease (LMD) after resection of brain metastases: results of the multicenter SUBAROMA studyLaura Mühlhausen, Martin Kocher, Hanah Hadice Karadachi, et al.
International Journal of Molecular Sciences|October 14, 2022
Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal OriginCorinna Seliger, Anne-Louise Meyer, Verena Leidgens, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Cancers|April 30, 2021
Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous MetaboliteRaffaela S Berger, Christian J Wachsmuth, Magdalena C Waldhier, et al.
Cancers|November 20, 2020
Non-Invasive Prediction of <i>IDH</i> Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo <sup>1</sup>H-Magnetic Resonance Spectroscopy and Machine LearningElisabeth Bumes, Fro-Philip Wirtz, Claudia Fellner, et al.
Cell Cycle (Georgetown, Tex.)|May 11, 2016
Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2Corinna Seliger, Anne-Louise Meyer, Kathrin Renner, et al.
Neuro-Oncology|December 22, 2021
Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastasesAnna-Katharina Meißner, Robin Gutsche, Norbert Galldiks, et al.
BMC Cancer|September 4, 2009
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II studyChristoph P Beier, Christina Schmid, Thierry Gorlia, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their CaregiversAnna Fischl, Michael Gerken, Patricia Lindberg-Scharf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2016
Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor MimicMarkus Hutterer, Yvonne Ebner, Markus J Riemenschneider, et al.
Molecular Oncology|January 18, 2025
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survivalBarnabas Irmer, Darius Wlochowitz, Carolin Krekeler, et al.
Journal of Neuro-Oncology|July 10, 2026
Leptomeningeal disease (LMD) after resection of brain metastases: results of the multicenter SUBAROMA studyLaura Mühlhausen, Martin Kocher, Hanah Hadice Karadachi, et al.
International Journal of Molecular Sciences|October 14, 2022
Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal OriginCorinna Seliger, Anne-Louise Meyer, Verena Leidgens, et al.
Pageof 11